Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
SaleCommon Stock | 47,478 | $34.16 | $1,621,848.48 |
DisclosureSEC source: 0000078003-03-000292 · she518.xml · nonDerivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,023 Read SEC document |
| November 17, 2003 Filed Nov 19, 2003 18:40 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0000078003-03-000293 · ste519.xml · derivative · entry 5 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2005-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 24, 1996. Read SEC document |
| November 17, 2003 Filed Nov 19, 2003 18:40 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 180,000 | $33.99 | $6,118,200.00 |
DisclosureSEC source: 0000078003-03-000293 · ste519.xml · nonDerivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045,470 Read SEC document |
| November 17, 2003 Filed Nov 19, 2003 18:40 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 180,000 | $8.17 | $1,470,600.00 |
DisclosureSEC source: 0000078003-03-000293 · ste519.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,225,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 82 | $34.08 | $2,794.56 |
DisclosureSEC source: 0000078003-03-000279 · can506.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,334 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 47 | $34.08 | $1,601.76 |
DisclosureSEC source: 0000078003-03-000280 · cor507.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 43 | $34.08 | $1,465.44 |
DisclosureSEC source: 0000078003-03-000281 · har508.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,597 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 37 | $34.08 | $1,260.96 |
DisclosureSEC source: 0000078003-03-000282 · jac509.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 171 | $34.08 | $5,827.68 |
DisclosureSEC source: 0000078003-03-000283 · kat510.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,191 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 53 | $34.08 | $1,806.24 |
DisclosureSEC source: 0000078003-03-000284 · kin511.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,849 Underlying: Common Stock · 53 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 377 | $34.08 | $12,848.16 |
DisclosureSEC source: 0000078003-03-000285 · mck512.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,359 Underlying: Common Stock · 377 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 358 | $34.08 | $12,200.64 |
DisclosureSEC source: 0000078003-03-000286 · mit513.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,098 Underlying: Common Stock · 358 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 135 | $34.08 | $4,600.80 |
DisclosureSEC source: 0000078003-03-000287 · nor514.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,816 Underlying: Common Stock · 135 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 354 | $34.08 | $12,064.32 |
DisclosureSEC source: 0000078003-03-000288 · she515.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,845 Underlying: Common Stock · 354 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 03, 2003 Filed Nov 4, 2003 16:01 UTC |
CORR PETER BSenior Vice President
|
SaleCommon Stock | 35,044 | $31.62 | $1,108,091.28 |
DisclosureSEC source: 0000078003-03-000255 · cor505.xml · nonDerivative · entry 2 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,050 Read SEC document |
| November 03, 2003 Filed Nov 4, 2003 16:01 UTC |
CORR PETER BSenior Vice President
|
SaleCommon Stock | 37,900 | $31.63 | $1,198,777.00 |
DisclosureSEC source: 0000078003-03-000255 · cor505.xml · nonDerivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,094 Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 64 | $31.60 | $2,022.40 |
DisclosureSEC source: 0000078003-03-000254 · can496.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,252 Underlying: Common Stock · 64 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 48 | $31.60 | $1,516.80 |
DisclosureSEC source: 0000078003-03-000255 · cor505.xml · derivative · entry 4 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 667 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 28 | $31.60 | $884.80 |
DisclosureSEC source: 0000078003-03-000256 · har497.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,554 Underlying: Common Stock · 28 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 27 | $31.60 | $853.20 |
DisclosureSEC source: 0000078003-03-000257 · jac498.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 62 | $31.60 | $1,959.20 |
DisclosureSEC source: 0000078003-03-000258 · kat499.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,020 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $31.60 | $1,548.40 |
DisclosureSEC source: 0000078003-03-000259 · kin500.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,796 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 115 | $31.60 | $3,634.00 |
DisclosureSEC source: 0000078003-03-000260 · mck501.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,982 Underlying: Common Stock · 115 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 154 | $31.60 | $4,866.40 |
DisclosureSEC source: 0000078003-03-000261 · mit502.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,740 Underlying: Common Stock · 154 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 31 | $31.60 | $979.60 |
DisclosureSEC source: 0000078003-03-000262 · nor503.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,681 Underlying: Common Stock · 31 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 225 | $31.60 | $7,110.00 |
DisclosureSEC source: 0000078003-03-000263 · she504.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,491 Underlying: Common Stock · 225 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 17, 2003 Filed Oct 20, 2003 18:09 UTC |
NORTON ROBERT WSenior Vice President
|
GiftCommon Stock | 620 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000245 · nor494.xml · nonDerivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,900 Read SEC document |
| October 15, 2003 Filed Oct 15, 2003 19:11 UTC |
NORTON ROBERT WSenior Vice President
|
GiftCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000233 · nor483.xml · nonDerivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,520 Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 68 | $30.60 | $2,080.80 |
DisclosureSEC source: 0000078003-03-000234 · can484.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,188 Underlying: Common Stock · 68 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 49 | $30.60 | $1,499.40 |
DisclosureSEC source: 0000078003-03-000235 · cor485.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 619 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 31 | $30.60 | $948.60 |
DisclosureSEC source: 0000078003-03-000236 · har486.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,526 Underlying: Common Stock · 31 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC |
JACKSON YVONNE RSenior VP - Human Resources
|
GrantPhantom Stock Units SSP · Derivative | 27 | $30.60 | $826.20 |
DisclosureSEC source: 0000078003-03-000237 · jac487.xml · derivative · entry 1 JACKSON YVONNE R · CIK 0001098930 · Senior VP - Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27 Underlying: Common Stock · 27 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 70 | $30.60 | $2,142.00 |
DisclosureSEC source: 0000078003-03-000238 · kat488.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,958 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:48 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $30.60 | $1,560.60 |
DisclosureSEC source: 0000078003-03-000239 · kin489.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,747 Underlying: Common Stock · 51 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:48 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 133 | $30.60 | $4,069.80 |
DisclosureSEC source: 0000078003-03-000240 · mck490.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,867 Underlying: Common Stock · 133 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:48 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 188 | $30.60 | $5,752.80 |
DisclosureSEC source: 0000078003-03-000241 · mit491.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,586 Underlying: Common Stock · 188 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:48 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $30.60 | $1,377.00 |
DisclosureSEC source: 0000078003-03-000242 · nor492.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,650 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:48 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 245 | $30.60 | $7,497.00 |
DisclosureSEC source: 0000078003-03-000243 · she493.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,266 Underlying: Common Stock · 245 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 06, 2003 Filed Oct 7, 2003 18:55 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,109 | $0.00 Strike: $22.77 | $0.00 |
DisclosureSEC source: 0000078003-03-000228 · cor471.xml · derivative · entry 4 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,109 shares Expires 2003-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| October 06, 2003 Filed Oct 7, 2003 18:55 UTC |
CORR PETER BSenior Vice President
|
Tax withholdingCommon Stock | 1,597 | $30.82 | $49,219.54 |
DisclosureSEC source: 0000078003-03-000228 · cor471.xml · nonDerivative · entry 2 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,994 Read SEC document |
| October 06, 2003 Filed Oct 7, 2003 18:55 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionCommon Stock | 20,109 | $22.77 | $457,881.93 |
DisclosureSEC source: 0000078003-03-000228 · cor471.xml · nonDerivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,731 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · derivative · entry 13 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,731 shares Expires 2003-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 32,763 | $0.00 Strike: $22.77 | $0.00 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · derivative · entry 12 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,109 Underlying: Common Stock · 32,763 shares Expires 2003-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $22.77 | $0.00 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · derivative · entry 11 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,872 Underlying: Common Stock · 5,000 shares Expires 2003-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,731 | $0.00 Strike: $9.72 | $0.00 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · derivative · entry 10 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,731 shares Expires 2003-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is currently exercisable Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Tax withholdingCommon Stock | 12,079 | $30.87 | $372,878.73 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 8 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,482 Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Tax withholdingCommon Stock | 2,616 | $30.87 | $80,755.92 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 7 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,561 Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Tax withholdingCommon Stock | 399 | $30.87 | $12,317.13 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 6 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,177 Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Tax withholdingCommon Stock | 3,699 | $30.87 | $114,188.13 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 5 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,576 Read SEC document |
| October 02, 2003 Filed Oct 6, 2003 17:56 UTC |
CORR PETER BSenior Vice President
|
Exercise / conversionCommon Stock | 17,731 | $16.72 | $296,462.32 |
DisclosureSEC source: 0000078003-03-000227 · cor469.xml · nonDerivative · entry 4 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.